LOINC
Version 2.73

100712-9Brexpiprazole [Mass/volume] in Serum or PlasmaActive

Part Description

LP429469-2   Brexpiprazole
Brexpiprazole is known as 'atypical' antipsychotic drug approved by the FDA in July 2015 for treatment of schizophrenia and adjunctive therapy for major depressive disorder. [PMID:PMC6007711] Source: Regenstrief LOINC

Fully-Specified Name

Component
Brexpiprazole
Property
MCnc
Time
Pt
System
Ser/Plas
Scale
Qn
Method

Additional Names

Short Name
Brexpiprazole SerPl-mCnc
Display Name
Brexpiprazole [Mass/Vol]
Consumer Name Alpha
Brexpiprazole, Blood

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.73
Last Updated
Version 2.73
Order vs. Observation
Both

Language Variants Get Info

zh-CNChinese (China)
依匹哌唑:质量浓度:时间点:血清/血浆:定量型:
nl-NLDutch (Netherlands)
brexpiprazol:massa/volume:moment:serum of plasma:kwantitatief:
it-ITItalian (Italy)
Brexpiprazolo:MCnc:Pt:Siero/Plasma:Qn:
es-ESSpanish (Spain)
Brexpiprazol:Concentración de masa:Punto temporal:Suero o Plasma:Qn:

Example Units

Unit Source
ug/mL Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=100712-9